“…However, 20–50% of patients operated on for clinical T1–T2 tumors show extraprostatic spread at pathological examination. Current clinical methods used preoperatively to predict the extent of disease are still of limited value for a given patient [1, 2, 3]. Biopsy features have been extensively studied for this purpose and the usefulness of some of these characteristics (number of positive biopsy cores, length of invaded tissue within biopsy cores) has been clearly confirmed [4, 5, 6].…”